presented three patients on dual biologics for rheumatic disease (two RA and other with Crohn ́s-associated arthritis) and concomitant asthma, combining mepolizumab or omalizumab with anti-TNF and no SAEs were reported (52). The gene discussed is TNF; the disease is rheumatoid arthritis.